Cited by 236Gut microbiota and healthPsoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Gut microbiota dysbiosis in a cohort of patients with psoriasis

Hidalgo‐Cantabrana, C., Gómez, J., Delgado, S., Requena‐López, S., Queiro‐Silva, R., Margolles, A., Coto, E., Sánchez, B. +1 more·2019·British Journal of Dermatology

Abstract

BACKGROUND: There is increasing evidence of the key role that the gut microbiota plays in inflammatory diseases. OBJECTIVES: To identify differences in the faecal microbial composition of patients with psoriasis compared with healthy individuals in order to unravel the microbiota profiling in this autoimmune disease. METHODS: 16S rRNA gene sequencing and bioinformatic analyses were performed with the total DNA extracted from the faecal microbiota of 19 patients with psoriasis and 20 healthy individuals from the same geographic location. RESULTS: Gut microbiota composition of patients with psoriasis displayed a lower diversity and different relative abundance of certain bacterial taxa compared with healthy individuals. CONCLUSIONS: The gut microbiota profile of patients with psoriasis displayed a clear dysbiosis that can be targeted for microbiome-based therapeutic approaches. What's already known about this topic? Psoriasis is a chronic inflammatory immune-mediated skin disease, the aetiology of which remains unclear. The human microbiota is a complex microbial community that inhabits our body and has been related with the maintenance of a healthy status. Several studies have focused on the skin microbiome and its connection with psoriasis although less attention has been focused on the potential role of the gut microbiota in psoriatic disease. What does this study add? This study unravels the gut microbiome dysbiosis present in a cohort of patients with psoriasis, compared with a healthy control group from the same geographical location. This study shows a lower bacterial diversity and different relative abundance of certain bacterial taxa in patients with psoriasis. We gain knowledge and insight into the microbiome alterations in psoriatic disease, opening new avenues for therapeutic approaches to reshape the human microbiome towards a healthy status.

Integrity signals

Registry

Crossref · 10.1111/bjd.17931

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hidalgo‐Cantabrana, C., Gómez, J., Delgado, S., Requena‐López, S., Queiro‐Silva, R., Margolles, A., Coto, E., Sánchez, B., & Coto‐Segura, P.
Affiliations
  • Department of Microbiology and Biochemistry of Dairy Products Instituto de Productos Lácteos de Asturias‐Consejo Superior de Investigaciones Científicas (IPLA‐CSIC) Paseo Río Linares s/n 33300 Villaviciosa Asturias Spain
  • Hospital Universitario Central de Asturias (ES)
  • Consejo Superior de Investigaciones Científicas (ES)
  • Dermatology andHospital Universitario Central de Asturias Oviedo Spain
  • Department of Rheumatology Hospital Universitario Central de Asturias Oviedo Spain
  • Hospital Vital Álvarez-Buylla (ES)
Corresponding author
Coto‐Segura, P.
Venue
British Journal of Dermatology
Published
2019-07-18
Volume
181
Issue
6
Pages
1287-1295
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W2935560613
Cited by
236
References
64
Citations by year
2026: 21 · 2025: 34 · 2024: 58 · 2023: 31 · 2022: 28 · 2021: 40 · 2020: 17 · 2019: 6
FWCI
7.53
Type
journal article
Language
en
Open access
closed
Locations
  • British Journal of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
Funders
Fundación Científica Asociación Española Contra el Cáncer (PS‐2016)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Keywords
psoriasis, gut microbiota, dysbiosis, fecal microbiota, bacterial diversity, bacterial taxa, microbiota-based therapy, autoimmune skin disease, inflammatory diseases
MeSH terms
Gastrointestinal Microbiome, Adult, DNA, Bacterial, Feces, Female, Humans, Male, Middle Aged, Psoriasis, RNA, Ribosomal, 16S, Cohort Studies, Healthy Volunteers, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review